Many of the analytes included in the assay are metabolites, and corresponding parent compounds that are not included will not be detected. This is due to rapid metabolism of certain drug analytes that are not eliminated in urine as the parent compounds. In these cases, the metabolites often have a longer half-life, meaning they are able to be detected for a longer window of time even after the parent compound has been completely eliminated. Because of the specific metabolism of each analyte, the parent compound is not always the specific structure being detected by the assay; instead, metabolites may be used to determine if certain drugs were used. For example, the opioid and illicit drug heroin has an extremely short half compared to other substances, and only the metabolite 6-MAM is detected in the urine for a positive result.
“Inconsistent” IndikoTM analysis results indicate that the urine samples may have been tampered with to the extent that it does not fall within the range of pH, creatinine, oxidants, or specific gravity for average, “normal” urine. While abnormal levels could be due to the medications, diet, or fluid intake, and not contaminants, “inconsistent” urine is flagged for clinicians to have a better understanding of the patient’s analysis.
“Abnormal” urine is also flagged due to the possibility that something may have been added to the urine sample, skewing results, though these values are closer to those of “normal” urine. In this context, “inconsistent” means that it is impossible to reach these adulterant values for human urine without manipulation, even under extreme pathophysiological conditions.